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Abstract 
Ferroportin (FPN), the sole characterized iron exporter, is mainly controlled by the peptide 
hormone hepcidin in response to iron, erythroid factors, hypoxia, and inflammation. In addition, 
intracellular iron level controls FPN translation by modulating the binding of Iron Responsive 
Proteins at the 5’UTR of FPN mRNA. Recently, Hypoxia Inducible Factor (HIF)2α has been 
shown to regulate FPN expression in intestinal cells. 
Here we show that, during experimentally-induced acute anemia in mice, FPN is regulated at 
transcriptional level in a cell-specific manner. FPN mRNA level increases in duodenum and 
spleen macrophages, whereas it does not change in liver and is strongly down-regulated in 
erythroid precursors. These results were confirmed in Caco2 Raw264.7 and K562 cells treated 
with a hypoxic stimulus. Moreover, we found  a differential expression of  HIF1α and HIF2α in 
cells and tissues that might account for the specificity of FPN regulation. 
Thus, hypoxia, by directly controlling hepcidin and its target FPN, orchestrates a complex 
regulatory network aimed at ensuring rapid iron recovery from the periphery and efficient iron 
utilization in the erythroid compartment. 
 
 
Introduction 
 
Iron homeostasis is maintained through the tight regulation of iron absorption by the intestine, 
iron recycling by macrophages and iron utilization mainly for hemoglobin synthesis [1]. 
Ferroportin (FPN) plays a crucial role in iron homeostasis being the only known iron exporter 
responsible for iron delivery from enterocytes and macrophages to the plasma, and for iron export 
from tissues stores [2; 3].  
FPN expression is mainly regulated at a post-translational level by the peptide hormone hepcidin 
[4]. Following hepcidin binding to FPN, FPN is internalized, phosphorylated and subsequently 
degraded by lysosomes [5; 6]. When hepcidin concentration is low, the rate of FPN synthesis is 
greater than its degradation, resulting in higher amounts of FPN at the cell surface, thus increasing 
iron export. On the contrary, high hepcidin levels lead to FPN degradation and consequently to 
iron retention. 
Moreover, FPN expression is regulated at a post-transcriptional level by intracellular iron 
concentration through the Iron Responsive Element (IRE) located in the 5’-untranslated region 
(UTR) of its mRNA [7; 8]. The importance of this element is highlighted by alterations in iron 
homeostasis seen in Pmc mice bearing a deletion in the FPN promoter region, which alters 
transcription start sites and eliminates the IRE in the 5'-UTR [9].  
Recently, Taylor and co-authors demonstrated that FPN was induced under conditions of low iron 
by the transcription factor Hypoxia Inducible Factor (HIF)2α [10]. 
Finally, other papers demonstrated that FPN expression is also regulated at the mRNA level by 
hemoglobin/heme, hypoxia and inflammation [3; 11; 12; 13; 14; 15; 16].  
The aim of this work is to analyse FPN regulation after acute anemia, a pathologic condition 
characterized by enhanced erythropoiesis, increased iron absorption and recycling, and rapid iron 
mobilization from hepatic stores.  
 
Materials and Methods 
 
Mice and treatment 
Three month-old wild-type 129Sv male mice were used for experiments. Phlebotomy was 
performed by retro-orbital bleeding: a total of 1.5 ml of blood was extracted in two lots over 48 
hours. Experiments were performed 1, 3 and 7 days after the first bleeding. Hematological 
parameters were determined by using an automatic analyzer (Dasit Sysmex XE-2100). 
All experiments were approved by the animal studies committee of the University of Torino 
(Italy).  
 
Determination of Tissue Iron Content 
Mice were perfused via the aorta with PBS and non-heme tissue iron content was determined as 
previously reported [13]. 
 
Western blotting 
Fifty µg of total protein extracts were separated on 8% SDS-PAGE and analyzed by Western 
blotting using antibodies against FPN [2] and actin (Santa Cruz Biothecnology Inc., Santa Cruz, 
California, USA).   
 
Quantitative real-time polymerase chain reaction 
Total RNA was extracted from tissue and cell samples using Micro-to-Midi Total RNA 
Purification System (Invitrogen, San Giuliano Milanese, MI, Italy). For quantitative real-time 
polymerase chain reaction (qRT-PCR), 1 µg total RNA was transcribed into complementary DNA 
(cDNA) by M-MLV reverse transcriptase (Invitrogen) and random primers (Invitrogen). qRT-
PCR was performed on a 7300 Real Time PCR System (Applied Biosystems, Monza, Italy) using 
Universal Probe Library System (Roche Diagnostics Corp., Milano, Italy) as previously described 
[13]. Primers and probes are listed in Supplementary Table S1. 
 
Nuclear protein extraction and Western blotting  
Cells treated with CoCl2 were washed once in PBS and lysed in Buffer A (10 mM Hepes pH 7.9, 
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT) on ice for 15 minutes. Cells were lysed with a needle 
and then centrifuged for 20 seconds at 12000g. Supernatant was discarded, the pellet washed with 
PBS and resuspendend in Buffer B (20 mM Hepes pH7.9, 25% (v/v) Glycerol, 0.42 NaCl, 1.5 
mM MgCl2, 0.2 EDTA, 0.5 mM DTT, 0.5mM PMSF, 1% Protease Inhibitor (Roche) followed by 
rotation at 4°C for 30 minutes. After centrifugation at 12000g at 4°C, the supernatant containing 
nuclei was collected, and protein concentration was determined using the Bio-rad Assay (Biorad, 
München, Germany). Fifty µg of nuclear protein extracts were separated on 10% SDS-PAGE, and 
analyzed by Western blotting using a mouse monoclonal anti-HIF1α antibody (NB100-105; 
Novus Biologicals), a rabbit polyclonal anti-HIF2α antibody (NB100-122SS; Novus Biologicals) 
and a mouse monoclonal anti-HIF1β antibody (NB100-124; Novus Biologicals). 
 
Spleen cell separation  
Macrophages and erythroid precursor cells were isolated from spleen cell suspensions using 
CD11b and TER119 ferromagnetic microbeads respectively, according to the manufacturer’s 
instructions (Miltenyi Biotec, Calderara di Reno, BO, Italy). 
 
Cell  culture and treatments  
Raw264.7 cells (ATCC: TIB-71), K562 cells (ATCC: CCL-243™) and Caco2-cells (ATCC: 
HTB-37TM) were used for in vitro experiments. Hypoxia on Raw Raw264.7 cells and K562 cells 
was chemically induced using cobalt chloride (CoCl2; Sigma-Aldrich, Milano, Italy). After two 
hours of starvation, Raw264.7 and K562 cells were treated with 100-500 µM of CoCl2 in culture 
medium without FCS, for different times. To block transcription, Actinomycin D (Sigma-Aldrich) 
was used together with CoCl2 treatment at different concentration (from 10 to 100 µg/mL) for 24 
hours. 
For Caco-2 cells the hypoxia treatment was achieved by incubation for 6, 24, 48 hours in a 
hypoxia chamber (Billups-Rothenberg Inc., Del Mar CA) containing 1% oxygen., 5% carbon 
dioxide and 94% nitrogen gas. 
 
 
 
 Results  
FPN is regulated in a tissue specific manner following phlebotomy 
To gain an insight into the physiological response of FPN to experimentally-induced acute anemia 
in mice, we chose the bleeding model. A total of 1.5 ml of blood was extracted by retro-orbital 
puncture (in two lots) over 48 hours. Experiments were performed 1, 3 and 7 days after the first 
bleeding. Red blood cells (RBCs), hemoglobin (HGB), and hematocrit (HCT) values were 
reduced by approximately 50% in phlebotomized mice 3 days after phlebotomy, while 
reticulocytes were increased by approximately 60%. Expansion of the erythroid compartment was 
confirmed by the two-fold increase in spleen/body weight ratio 3 days after phlebotomy. Iron 
stores decreased significantly in the liver of phlebotomized mice (Figure 1A). As expected, qRT-
PCR analysis revealed a 80% decrease in hepcidin mRNA level in livers of phlebotomized mice 
(Figure 1B). Accordingly, FPN expression was strongly induced in liver and duodenum whereas 
we could not detect such induction in spleen extracts. However, the increase in FPN expression 
was evident in macrophages isolated from the spleen of phlebotomyzed mice (Figure 1C-F). 
These results were expected as it is well-established that anemia negatively regulates hepcidin, 
thus increasing the stability of FPN at the cell plasma membrane [6; 17]. 
More interesting were the results obtained from the analysis of FPN mRNA expression following 
phlebotomy. We found that FPN mRNA level was strongly increased in duodenum and spleen 
macrophages, whereas its level did not change in the liver and was significantly down-regulated 
in TER119+-spleen erythroid precursors (Figure 2).  
Thus, both changes in mRNA expression and protein stabilization, due to hepcidin down-
regulation, contibute to regulate FPN expression following phlebotomy.  
 Hypoxia regulates FPN transcription in a cell-specific manner 
We hypothesized that bleeding-induced hypoxia might be responsible for the tissue-specific 
regulation of FPN expression. HIF2α has already been shown to regulate FPN transcription in 
duodenum [10; 18]. Accordingly, FPN was induced in the intestinal cell line Caco2 following 
hypoxia (Figure 3A; Figure S1A). Similar results were obtained on Caco2 cells using a known 
and widely accepted hypoxia-mimicking agent, cobalt chloride (not shown). To assess whether 
hypoxia was also responsible for FPN up- and down-regulation in macrophages and erythroid 
progenitors respectively, FPN expression was analyzed in Raw264.7 (macrophage cell line) and 
K562 (erythroid-like cell line) cells treated for 24 hours with cobalt chloride (CoCl2) (Figure S1B-
C). After CoCl2 incubation, FPN mRNA was up-regulated in Raw264.7 cells and down-regulated 
in K562 cells (Figure 3B-C). The positive effect on FPN expression was at a transcriptional level, 
as actynomicin D blocks FPN mRNA induction in Raw264.7 cells in a dose-dependent manner 
(Figure 3D).  
 
HIF subunits are differentially expressed in cells and tissues 
Data reported in the previous paragraph demonstrated that hypoxia may both positively and 
negatively control FPN transcription. To further investigate this issue we analyzed expression of 
the different HIF subunits, HIF1α, HIF2α and HIF3α, as it has already been reported that 
differential expression of these proteins may be responsible for a distinct pattern of cellular 
expression [19].  The most abundant isoform in Raw264.7 cells was HIF1α whereas in K562 and 
Caco2 cells was HIF2α; HIF3α was expressed at negligible levels in each cell type (Figure 4). 
The same pattern of HIF subunits expression was also seen in vivo: the most abundant isoform in 
spleen macrophages was HIF1α whereas in the duodednum and erythroid cells was HIF2α (not 
shown).  
 
Discussion 
Here we demonstrated a tissue-specific regulation of FPN mRNA expression following 
phlebotomy: FPN mRNA increases in tissues that have to supply iron for erythropoiesis and 
decreases in erythroid progenitors that actively differentiate to recover anemia. 
Up-regulation of FPN expression at mRNA level has already been reported in duodenums isolated 
from mice exposed to hypoxia or fed on iron-deficient diet [3]. Treatment of CaCo2 cells with 
iron reduces FPN transcriptional rates while desferrioxamine treatment results in the opposite 
effect [16]. Moreover, iron loading of human alveolar macrophages [20] and murine J774 
macrophages [21] results in increased FPN mRNA. Finally, FPN mRNA levels increase in bone 
marrow-derived macrophages following erythrophagocytosis and heme treatment, [11; 22; 23] as 
well as in Raw264.7 cells after hemoglobin supplementation [13]. Inflammatory stimuli, such as 
LPS [12], TNFα [24] and turpentine oil [15] can also regulate FPN mRNA levels, both in vivo 
and in vitro. In addition, it has been reported that high-altitude exposure is associated with an 
increase in skeletal muscle FPN mRNA levels in humans [14]. 
Our data indicate that hypoxia consequent to bleeding may be responsible for the tissue-specific 
regulation of FPN expression as we were able to reproduce in vitro the same pattern of FPN 
expression observed in vivo by treating Caco2, Raw264.7 and K562 cells with an hypoxic 
stimulus. However we cannot rule out the possibility that other stimuli induced by bleeding may 
concur to regulate FPN expression. Among these, erythropoietin (EPO) has been shown to induce 
FPN expression in Caco2 cells [25] and in humans erythropoietin administration affects FPN 
expression in muscle [26] and in peritoneal exudates macrophages [27]. However, the 
administration of recombinant human EPO to mice did not affect FPN expression in the 
duodenum [28]. Whether EPO directly affect FPN promoter has not yet been investigated. 
Moreover, it has been reported that FPN promoter could be regulated by putative erythroid-
specific transcription factors, like GATA and KLF. Accordingly, FPN expression decreased both 
at the mRNA and protein levels during estradiol-induced erythroid differentiation of G1E-ER4 
cells [29]. Our data suggest that HIF may represent an additional transcription factor involved in 
the regulation of FPN expression at mRNA level in conditions of acute anemia. 
We showed that HIFα subunits are differentially expressed in mouse tissues, HIF1α being mainly 
expressed in macrophages and HIF2α in duodenal cells and erythroid progenitors. HIF-1α and 
HIF-2α are characterized by similar structures and both recognize the same DNA sequence. 
However, differences in their N-terminal activation domain and the requirement of specific 
transcriptional cofactors confer them specificity in the regulation of gene expression [30]. It has 
already been demonstrated that HIF1α and HIF2α subunits can exhibit opposite roles in the 
regulation of a single target. As an example, in endothelial cells HIF-1α diminishes the expression 
of interleukin-8 (IL-8) by inhibition of the Nrf2 transcription factor, while in the same cells HIF-
2α increases the expression of IL-8 in an Nrf2-independent way. Additionally, HIF-1 decreased, 
whereas HIF-2 increased, c-Myc expression [30]. Moreover, the complexity of the HIF regulatory 
system is further increased by the possibility of a single HIFα subunit to induce opposite effects 
on the same target gene in different cells. Indeed, Fenglan Lou et al. demonstrated that HIF-2α 
enhances telomerase reverse transcriptase (hTERT) gene expression in renal cell carcinoma 
(RCC) cell lines, whereas it represses the hTERT transcription in glioma cells [31]. 
Based on these observations, we speculate that the differential expression of HIF-1α and HIF-2α, 
together with tissue-specific co-factors, is responsible for the cell-specific regulation of FPN 
transcription. 
Hypoxia is a main regulator of iron homeostasis as it strongly down-regulates hepcidin [32], 
likely through a mechanism involving both  HIF1α and HIF2α [33]. It is intriguing that the same 
stimulus may both inhibit hepcidin expression and induce its target protein, FPN, in duodenum 
and macrophages, thus ensuring an adequate iron supply for erythropoiesis. On the other hand, in 
erythroid precursors hypoxia down-regulates FPN, as shown here, and induces transferrin 
receptor thus allowing efficient iron utilization [34].  
Thus, hypoxia orchestrates a complex regulatory network aimed at ensuring a rapid mobilization 
of iron from duodenum and macrophages and, on the other hand, at limiting the loss of iron, 
which is required for hemoglobin synthesis in erythroid precursors (Figure 5).  
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Legends for Figures 
Figure 1. Regulation of FPN expression following phlemotomy. 
(A) Phlemotomy model. Hematological parameters, liver iron and spleen/body weight ratio in 
untreated and phlebotomized mice 1, 3 and 7 days after the first bleeding. Data represent mean ± 
SEM; n=10 for each experimental point. * = P<0.05; ** = P<0.01; *** = P<0.001. (B) qRT-PCR 
analysis of hepcidin expression in the liver of untreated and phlebotomized mice, 3 days after the 
first bleeding. Transcript abundance, normalized to 18S RNA expression, is expressed as a fold 
increase over a calibrator sample. Data represent mean ± SEM; n=5; *** = P<0.001. Results 
shown are representative of 3 independent experiments. (C-F) Western blots of  FPN expression 
in liver, duodenum, spleen and CD11b+ cells isolated from the spleen of untreated and 
phlebotomized mice, 3 days after the first bleeding. A representative experiment for each tissue is 
shown. Band intensities were measured by densitometry and normalyzed to actin expression. Data 
represent mean ± SEM; n=3 for each experimental point. ** = P<0.01; *** = P<0.001. 
 
Figure 2. Cell-specific transcriptional regulation of FPN after phlebotomy. qRT-PCR 
analysis of FPN expression in liver (A) duodenum (B) spleen CD11b+ cells (C) and spleen 
TER119+ cells (D) of untreated and phlebotomized mice, 3 days after the first bleeding. 
Transcript abundance, normalized to 18S RNA expression, is expressed as a fold increase over a 
calibrator sample. Data represent mean ± SEM; n=3; * = P<0.05. Results shown are 
representative of 3 independent experiments. 
 
Figure 3. Hypoxia controls FPN transcription. (A) qRT-PCR analysis of FPN mRNA levels in 
Caco-2 cells following 6, 24 and 48 hours of hypoxia (1% oxygen). (B) qRT-PCR analysis of 
FPN mRNA levels in RAW 264.7 and K562 cells treated for 8, 12, 18 or 24 hours with 100 µM 
CoCl2. (D) qRT-PCR analysis of FPN expression in RAW264.7 treated for 24 hours with 100 µM 
CoCl2 and increasing amounts of actinomycin D. Transcript abundance, normalized to 18S RNA 
expression, is expressed as a fold increase over a calibrator sample. Data represent mean ± SEM; 
n=3; * = P<0.05; *** = P<0.001. Results shown are representative of 3 independent experiments. 
 
Figure 4. Differential expression of HIF α subunits. qRT-PCR analysis of HIF1α, HIF2α and 
HIF3α expression in RAW264.7 (A), K562 (B) and Caco-2 (C) cells. Transcript abundance, 
normalized to 18S RNA expression, is expressed as a fold increase over a calibrator sample. Data 
represent mean ± SEM; n=3 for each experimental point; ** = P<0.01; *** = P<0.001. Results 
shown are representative of 3 independent experiments. 
 
Figure 5. Cell-specific transcriptional regulation of FPN is mediated by different HIF 
subunits. We hypothesized that hypoxia may stabilize different HIFα subunits in different cell 
types. Stabilization of HIF1α in macrophages, in association with the constitutive HIF1β isoform, 
activates the transcription of FPN mRNA. HIF2α plays a role in the transcriptional activation of 
FPN mRNA in the duodenum [10]. In this manner hypoxia contributes at the transcriptional level 
to increase FPN expression in duodenum and macrophages, thus allowing increased iron 
absorption and mobilization to support erythropoiesis. 
Data reported here suggested that HIF2α could inhibit FPN transcription in erythroid progenitors. 
The down-regulation of FPN protein may be important to increase iron availability for heme 
synthesis in erythroid progenitors. 
We hypothesized that the association of HIF2α with cell-specific transcriptional activators or 
repressors could account for the differential role of HIF2α in modulating the transcription of FPN 
in duodenum and erythroid precursors. 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
